cefepime (cefepime hydrochloride) NDC 25021-122

NDC codes

FDA NDC Directory

Product NDC (as listed)25021-122Labeler and product segments. Claims need a package NDC.

Product NDC at billing width25021-0122Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
25021-122-50	25021012250	10 VIAL in 1 CARTON (25021-122-50) / 20 mL in 1 VIALMarketed from May 1, 2008

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): cefepime
Generic name (nonproprietary): cefepime hydrochloride
Active ingredients: Cefepime hydrochloride — 2 g/20mL
Dosage form: Injection, Powder, For solution
Route: Intravenous
Labeler: Sagent Pharmaceuticals
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065441
Marketing start: May 1, 2008
Listing expires: Dec 31, 2027
Other FDA classes: Cephalosporins (Chemical structure)
Identifiers: Product ID 25021-122_f5f4ce71-3a77-4670-805b-4c346a0f9beaSPL ID f5f4ce71-3a77-4670-805b-4c346a0f9bea
Pharmacologic class: Cephalosporin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N425021012250 followed by a unit qualifier and the quantity

Package 25021-0122-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 065441

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065441
Product	Strength	Form · route	Labeler	Product NDC
Cefepime	Cefepime hydrochloride 1 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	Hospira, Inc.	0409-9566
Cefepime	Cefepime hydrochloride 2 g/1	Injection, Powder, For solutionIntravenous	Hospira, Inc.	0409-9735
Cefepime	Cefepime hydrochloride 1 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	WG Critical Care, LLC	44567-240
Cefepime	Cefepime hydrochloride 2 g/1	Injection, Powder, For solutionIntravenous	WG Critical Care, LLC	44567-241
Cefepime	Cefepime hydrochloride 1 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	Fresenius Kabi USA, LLC	63323-326
Cefepime	Cefepime hydrochloride 2 g/1	Injection, Powder, For solutionIntravenous	Fresenius Kabi USA, LLC	63323-340
Cefepime	Cefepime hydrochloride 1 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	WG Critical Care, LLC	44567-130
Cefepime	Cefepime hydrochloride 2 g/1	Injection, Powder, For solutionIntravenous	WG Critical Care, LLC	44567-131
cefepimecefepime hydrochloride	Cefepime hydrochloride 1 g/20mL	Injection, Powder, For solutionIntramuscular, Intravenous	Sagent Pharmaceuticals	25021-121